1. Home
  2. HURC vs MGNX Comparison

HURC vs MGNX Comparison

Compare HURC & MGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HURC
  • MGNX
  • Stock Information
  • Founded
  • HURC 1968
  • MGNX 2000
  • Country
  • HURC United States
  • MGNX United States
  • Employees
  • HURC N/A
  • MGNX N/A
  • Industry
  • HURC Industrial Machinery/Components
  • MGNX Biotechnology: Pharmaceutical Preparations
  • Sector
  • HURC Industrials
  • MGNX Health Care
  • Exchange
  • HURC Nasdaq
  • MGNX Nasdaq
  • Market Cap
  • HURC 104.0M
  • MGNX 114.2M
  • IPO Year
  • HURC N/A
  • MGNX 2013
  • Fundamental
  • Price
  • HURC $19.99
  • MGNX $1.71
  • Analyst Decision
  • HURC
  • MGNX Hold
  • Analyst Count
  • HURC 0
  • MGNX 9
  • Target Price
  • HURC N/A
  • MGNX $5.33
  • AVG Volume (30 Days)
  • HURC 44.2K
  • MGNX 1.2M
  • Earning Date
  • HURC 09-05-2025
  • MGNX 08-05-2025
  • Dividend Yield
  • HURC N/A
  • MGNX N/A
  • EPS Growth
  • HURC N/A
  • MGNX N/A
  • EPS
  • HURC N/A
  • MGNX N/A
  • Revenue
  • HURC $183,634,000.00
  • MGNX $154,050,000.00
  • Revenue This Year
  • HURC N/A
  • MGNX N/A
  • Revenue Next Year
  • HURC N/A
  • MGNX N/A
  • P/E Ratio
  • HURC N/A
  • MGNX N/A
  • Revenue Growth
  • HURC N/A
  • MGNX 255.31
  • 52 Week Low
  • HURC $13.19
  • MGNX $0.99
  • 52 Week High
  • HURC $23.76
  • MGNX $5.77
  • Technical
  • Relative Strength Index (RSI)
  • HURC 62.94
  • MGNX 59.62
  • Support Level
  • HURC $18.09
  • MGNX $1.47
  • Resistance Level
  • HURC $20.25
  • MGNX $1.88
  • Average True Range (ATR)
  • HURC 0.99
  • MGNX 0.12
  • MACD
  • HURC -0.14
  • MGNX 0.03
  • Stochastic Oscillator
  • HURC 56.38
  • MGNX 68.81

About HURC Hurco Companies Inc.

Hurco Companies Inc is a United States-based industrial technology company. It designs, manufactures, and sells computerized machine tools, consisting mainly of vertical machining centers and turning centers, to companies in the metalworking industry through sales, service, and distribution networks. The company concentrated on designing user-friendly computer control systems that both skilled and unskilled machine tool operators can operate. It generates maximum revenue from the Computerized Machine Tools product. Geographically, It derives a majority of its revenue from the United States of America. Its product categories include 5-Axis VMC; 3-Axis VMC; Horizontal MC and Turning Centers.

About MGNX MacroGenics Inc.

Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast cancer. It's a pipeline of product candidates designed to target either various tumor-associated antigens or immune checkpoint molecules. The company has three proprietary product candidates in clinical development: lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload, and MGC028, an ADC that targets ADAM9 and delivers a novel TOP1i-based linker-payload.

Share on Social Networks: